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Background
Over the last half-century or more, vaccination, as one of the most 
cost effective public health interventions ever, has been key to 
reducing child morbidity and mortality worldwide1. Vaccination is 
essential to preventing target diseases of interest2. Consequently, 
coverage above the minimum thresholds for the target disease or 
global targets is required to enjoy the full benefits of vaccination1,3,4. 
Vaccination coverage is a performance indicator of immunisa-
tion programmes, which is also used to track global and national 
progress in the control of vaccine-preventable diseases (VPD). It 
is also an eligibility criterion for funding in many low and middle-
income countries (LMICs)5. 
With massive global and national investments in vaccination pro-
grammes, there have been significant improvements in global 
childhood vaccination coverage. For example the proportion of 
children who received the third dose of diphtheria-tetanus-pertussis 
vaccine (DTP3) by 12 months of age increased from 5% in 1974 to 
86% in 2015 (http://www.who.int/immunization/monitoring_sur-
veillance/who-immuniz-2015.pdf?ua=1)6. Unfortunately, DTP3 
coverage has since stagnated at 85% since 2010 and many LMICs 
in sub-Saharan Africa (sSA), Eastern Mediterranean and South 
East Asia Regions of the world have not attained the recommended 
targets of 90% national vaccination coverage and <10% dropout 
between vaccine doses. (http://www.who.int/immunization/glo-
bal_vaccine_action_plan/en/ and http://www.who.int/immuniza-
tion/monitoring_surveillance/who-immuniz-2015.pdf?ua=1)
These global data masks the widely variable vaccination coverage 
in LMICs, particularly in sSA countries that only attained 76% 
DTP3 coverage in 20156. Besides, there are also regional differ-
ences in DTP3 coverage of 69% in West and Central compared to 
79% in Eastern and Southern Africa (http://data.unicef.org/core-
code/uploads/document6/uploaded_pdfs/corecode/Immuniza-
tion_Summary_2012_Eng_40) . When the fully immunised child 
is considered, less than half of children in its Eastern region are 
fully immunised7. There are also widely varying vaccination cov-
erage in countries within a region, for example overall DTP3 
coverage ranges from 56% in Nigeria to 97% in The Gambia 
(http://apps.who.int/immunization_monitoring/globalsummary/co
untries?countrycriteria[country][]=GMB). Yet achieving and main-
taining high vaccination coverage could potentially avert millions 
of VPD-related deaths in children and yield into an estimated $63 
billion in savings during the decade 2011 – 20208. Good quality 
vaccination data is required to understand inequities in access to 
vaccines. Most vaccination coverage estimates in LMICs are from 
administrative reports that tend to overestimate coverage, due to 
errors in the number of vaccine doses administered and/or invalid 
assumptions about the size of the target population of children.
DPT3 for children sampled between 12 and 23 months is the prin-
cipal surrogate measure of vaccination coverage and performance 
of national immunization programmes. However, the proportions 
of fully immunised children are often considered better indica-
tors of the full benefits of immunisation compared to DPT3 within 
countries9.
Using datasets from the Demographic and Health Surveys Program 
(DHS: https://dhsprogram.com/), we conducted a comprehensive 
review of the trends in vaccination coverage, dropouts between 
vaccine doses and country-specific predictors of a fully immunised 
child (FIC) in the West African region.
Methods
Study area and population
This study utilized datasets from DHS conducted in 13 West African 
countries: Benin, Burkina Faso, Cote d’Ivoire, The Gambia, Ghana, 
Guinea, Liberia, Mali, Niger, Nigeria, Senegal, Sierra Leone and 
Togo. DHS methodology encompasses a two-stage cluster sample 
design that produces unique, consistent, and nationally representa-
tive data that are comparable across countries10. While these DHS 
datasets are not primarily carried out to collect vaccination data, 
they incorporate a questionnaire for women of reproductive age 
(15–49 years) for maternal and child health (including immunisa-
tion) in relation to all births within the preceding five years5. DHS 
survey interviewers obtain immunization information from vaccine 
cards and/or mother’s/respondent’s recall.
For countries with multiple datasets between 2000 and 2013, we 
assessed trends in vaccination coverage using their two most recent 
standard DHS datasets, as follows: Benin (2006 and 2011–12); 
Burkina Faso (2003 and 2010); Ghana (2003 and 2008); Guinea 
(2005 and 2012); Liberia (2007 and 2013); Mali (2006 and 2012–13); 
Niger (2006 and 2012); Nigeria (2008 and 2013); Senegal (2005 
and 2010–11) and Sierra Leone (2008 and 2013). The rest of the 
analyses to calculate dropouts and determine the predictors of a FIC 
included countries with single datasets (Cote d’Ivoire 2011–12, 
The Gambia 2013, and Togo 2013–14) and the most recent dataset 
for those countries with multiple datasets.
Data management and analysis
We followed the widely recommended strategy for measuring com-
plete vaccination status by restricting our datasets to children aged 
12–23 months and dropping all children that had passed away by 
the date of interviews7,11,12.
Our primary outcome was the fully immunised child (FIC). A FIC 
was defined as having received at birth or first contact, a dose of 
Bacille Calmette-Guérin vaccine (BCG), a 3-dose course of the 
diphtheria, pertussis and tetanus combination vaccine (DPT), and 
oral polio vaccine (OPV; given at 6, 10 and 14 weeks or at least four 
weeks apart) and a dose of measles-containing vaccine (MCV1; 
administered at 9 months), as reported by vaccine card or caregiver 
recall9,13. Other outcomes of interest in this study included access 
and utilization to immunization services. Good access was defined 
as having a DPT1 coverage of >80%, whereas a good utilization 
was defined as a DPT1-to-DPT3 dropout <10%14.
All statistical analyses were performed using STATA software, 
version 13.1 (StataCorp, Lakeway Drive, College Station, TX, 
USA). In descriptive analysis, we reported the proportions of FIC 
and those who received each vaccine dose by country, as well as the 
percentage DPT1-to-DPT3 and DPT1-to-MCV1 dropout15.
Chi-square tests were utilized in univariate analyses to examine 
associations between FIC and possible risk factors. The risk fac-
tors considered were: maternal age, maternal education, gender, 
religion, place of delivery, marital status, distance from home to 
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nearest health facility, possession of a vaccine card, number of sib-
lings, birth order, socio-economic status, rural or urban residence, 
and whether the child received a check-up within two months of 
birth7,13,16–21. Following this, we constructed multivariable logistic 
regression models within each country to examine the correlates of 
FIC. All factors identified at 10% significance (P-value <0.10) in 
univariate analysis were incorporated into the model. Before fitting 
the model, we assessed for potential collinearity using the Pearson’s 
R correlation coefficient (r > =0.8), and retained strongly correlated 
variables as suggested in the literature22,23.
To account for the complex DHS survey design, the svyset command 
in STATA was used to apply inverse probability weights (http://
www.ats.ucla.edu/stat/stata/faq/svy_introsurvey.htm). Adjusted 
odds ratios (AORs) and 95% confidence intervals are reported at a 
5% significance level.
Ethics statement
Ethical approval was not required for this study because it used 
anonymised DHS data. DHS surveys are conducted only after 
approvals have been given by the ICF International Institutional 
Review Board (IRB) and country IRBs for country-specific DHS 
survey protocols. In addition, written informed consent is obtained 
from each survey participant (http://www.dhsprogram.com/What-
We-Do/Protecting-the-Privacy-of-DHS-Survey-Respondents.cfm). 
The aggregate data utilised in this study was made freely available 
by DHS after after a simple registration process on their website 
(http://www.dhsprogram.com/data/new-user-registration.cfm), 
which includes providing an explaination for the need for the data-
sets and planned analyses.
Results
Coverage by vaccine and proportions of the FIC
As shown in Table 1, coverage for each vaccine also varied by 
country. For BCG, it ranged from 50.6% in Nigeria to 98.4% in The 
Gambia, with only seven countries attaining the 90% Global Vaccine 
Action Plan target. Similarly, DPT1-to-DPT3 coverage remained 
low in a number of countries, with DPT3 coverage not reaching the 
90% target in all countries. Despite similarly low OPV1-to-OPV3 
coverage proportions, a sharp difference in DPT3 and OPV3 was 
observed in Nigeria – 38.0% and 53.3%, respectively. For measles, 
the 90% target was only achieved in Ghana (90.2%).
The proportions of the FIC varied across the 13 countries ranging 
from 24.1% in Nigeria to 81.2% in Burkina Faso (Table 2). These 
proportions were significantly different (p< 0.01). Burkina Faso 
also had the lowest numbers of partially vaccinated children. The 
highest proportions of completely unvaccinated and partially vacci-
nated children were seen in Nigeria, whereas Ghana had the lowest 
proportion of unvaccinated children.
Trend in vaccination coverage
Across all 10 countries, there was an overall increase in vaccination 
coverage for all vaccines, but country-specific coverage actually 
declined by over 25% in Benin and Mali when their last two DHS 
datasets are compared (see Table 3). BCG coverage increased in 
all countries except in Benin. In particular, Burkina Faso, Liberia, 
and Niger achieved substantial improvements in coverage of this 
vaccine.
DPT1 coverage declined in five countries - Benin, Guinea, Mali, 
Nigeria and Senegal - while DPT2 coverage increased in all coun-
tries except Benin, Liberia, and Mali. The biggest gains in DPT3 
coverage was seen in Niger, Burkina Faso, Liberia and Sierra 
Leone. For DPT3, none of the countries attained the 90% target, 
with three countries recording a decline in coverage (see Table 1 
and Table 3).
For the polio vaccines, OPV1, OPV2, and OPV3 coverage increased 
in all countries except for Benin and Mali, where there was a 27% 
Table 1. Percentage coverage for each vaccine in children aged 12–23 months across selected West 
African countries. BCG, Bacille Calmette-Guérin vaccine; DPT, diphtheria, pertussis and tetanus; OPV, 
oral polio vaccine; FIC, fully immunised child.
Country Survey year BCG DPT1 DPT2 DPT3 OPV1 OPV2 OPV3 Measles FIC
Benin 2011–12 86.0 69.0 65.6 58.7 81.1 75.3 53.1 67.8 35.0
Burkina Faso 2010 96.4 94.3 92.7 89.5 97.3 95.5 90.2 87.3 81.2
Cote d’Ivoire 2011–12 83.0 77.4 71.6 63.8 91.1 83.7 69.0 63.9 49.6
Gambia 2013 98.4 94.1 93.3 87.8 96.6 94.3 88.7 87.3 72.5
Ghana 2008 95.7 97.5 95.5 89.3 96.7 94.3 86.8 90.2 78.8
Guinea 2012 82.3 75.5 62.3 49.9 84.2 71.4 51.1 61.4 36.1
Liberia 2013 93.8 91.3 82.0 71.5 95.4 86.8 70.3 74.1 54.6
Mali 2012–13 78.3 74.2 68.8 58.6 77.5 70.3 45.2 66.6 33.9
Niger 2012 83.5 85.2 78.4 68.2 91.2 84.6 75.3 68.0 51.0
Nigeria 2013 50.6 50.0 45.1 38.0 75.8 69.4 53.3 41.4 24.1
Senegal 2010–11 93.8 92.9 89.9 81.8 93.8 89.9 72.1 81.1 60.6
Sierra Leone 2013 95.4 93.0 88.2 78.1 93.5 88.3 77.9 77.9 67.0
Togo 2013–14 95.0 92.9 89.1 82.5 93.7 88.9 73.8 74.1 60.5
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reduction in coverage. OPV3 coverage also declined slightly in 
Senegal. For OPV3, the biggest gains in coverage were seen in 
Sierra Leone, Burkina Faso, Liberia, Nigeria and Niger.
Despite a decline in coverage of all other vaccines in Benin, MCV1 
coverage actually increased, which was also seen in all other coun-
tries except Mali. The biggest gains in MCV1 coverage were seen 
in Burkina Faso, Niger and Sierra Leone. Recommended MCV1 
coverage targets were not met in any of these West African coun-
tries, except for Ghana (Table 1).
Across all countries, there were major reductions in the number 
of unvaccinated children, ranging from 22–81% reduction, except 
in Benin and Mali where they increased by 70% and 36%, respec-
tively. Similarly, the proportions of the FIC increased in most coun-
tries, except Benin, Guinea, and Mali.
Dropout proportions
DPT1-to-DPT3. The proportion of DPT1-to-DPT3 dropouts var-
ied across countries ranging from 5.1% in Burkina Faso to a high 
of 33.9% in Guinea. All except three countries - Burkina Faso, 
Gambia, and Ghana - had high DPT-1-to-DPT-3 dropouts (i.e. 
>10%)24,25, indicating a region-wide problem with utilisation of 
immunisation services (Table 4). Based on their low DPT1 cover-
age (<80%), five out of 13 countries also had poor access to immu-
nisation services24,25. Three out of 13 countries reported high DPT1 
coverage (>80%), a correlate of good access to immunisation serv-
ices, and a low DPT1-to-DPT3 dropout (<10%), which is an indica-
tion of good utilization of these services.
DPT1-to-MCV1. Given the DPT1-to-MCV1 dropout of <10% in 
Benin, Burkina Faso, Ghana and The Gambia, children in these 
countries were more likely to have received all the recommended 
vaccines by one year of age compared to children from all other 
countries reviewed (Figure 1).
Predictors of complete vaccination status
In univariate analysis, possession of a vaccine card was associated 
with increased likelihood of FIC status in all countries. In addi-
tion, delivery at a hospital/health facility, and attendance of a well-
baby clinic for review/check-up within two months of birth were 
related to complete vaccination in all countries, except Gambia and 
Ghana.
Although many countries shared the same predictors or risk 
factors for complete vaccination in multivariable regression 
models, the results were still quite variable as shown in the AORs 
presented in Table 5. Delivery at a health facility remained a signifi-
cant predictor of a FIC, such that children born at a health facility 
were 1.5–2.3 times more likely to be fully immunised compared to 
those born at home in Benin, Burkina Faso, Cote d’Ivoire, Guinea, 
and Nigeria.
Table 4. Proportion of dropouts beween DPT1 and DPT3 in West African children aged  











Benin 58.7 69.0 10.3 14.9 Poor Poor 4
Burkina 
Faso 89.5 94.3 4.8 5.1 Good Good 1
Cote 
d’Ivoire 63.8 77.4 13.6 17.6 Poor Poor 4
Gambia 87.8 94.1 6.3 6.7 Good Good 1
Ghana 89.3 97.5 8.2 8.4 Good Good 1
Guinea 49.9 75.5 25.6 33.9 Poor Poor 4
Liberia 71.5 91.3 19.8 21.7 Good Poor 2
Mali 58.6 74.2 15.6 21.0 Poor Poor 4
Niger 68.2 85.2 17.0 20.0 Good Poor 2
Nigeria 38.0 50.0 12.0 24.0 Poor Poor 4
Senegal 81.8 92.9 11.1 11.9 Good Poor 2
Sierra 
Leone 78.1 93.0 14.9 16.0 Good Poor 2
Togo 82.5 92.9 10.4 11.2 Good Poor 2
Drop out = DPT1 – DPT3
Dropout % = (Dropout/DPT1)* 100
1 = Drop-out rates are low (<10%)= good utilization & DPT1 coverage is high (>=80%)= good access
2 = Drop-out rates are high (>=10%)= poor utilization & DPT1 coverage is high (>=80%)= good access
3 = Drop-out rates are low (<10%)= good utilization & DPT1 coverage is low (<80%)= poor access
4 = Drop-out rates are high (>=10%)= poor utilization & DPT1 coverage is low (<80%)= poor access
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Possession of a vaccine card was also significantly associated with 
full immunisation in all countries, except in Ghana, and the effect 
size was particularly significant in Togo where those with a vaccine 
card were almost 14 times more likely to be fully immunised.
Children who attended a check-up/clinic appointment within two 
months of birth had significantly greater odds of a FIC status in nine 
countries: Benin, Burkina Faso, Cote d’Ivoire, Guinea, Mali, Niger, 
Nigeria, Senegal and Togo.
In Liberia, Nigeria, and Togo, birth order was an important predic-
tor of FIC. Compared to first-born children, second-born or higher 
birth order children had lower odds of FIC status only in Liberia, 
Nigeria, and Togo. Maternal education was also an important pre-
dictor of FIC in Cote d’Ivoire, Liberia, and Senegal, while the dis-
tance from vaccine clinics reduced the odds of FIC in Mali and 
Niger. The direction of the effects of socio-demographic factors 
like maternal marital status and rural residence on FIC status were 
not consistent across these West African countries. For example, 
rural residence was a predictor of FIC in The Gambia, but con-
tributed to lower odds of full immunisation in Ivoirian children. 
Similarly, children born to mothers who were married or previously 
married were 2.2–9.7 times more likely to be fully immunised in 
Ghana, but this was 0.3–0.5 times lower in Senegal.
Discussion
Despite the promising trend of increasing vaccination coverage 
observed in the region, the mean prevalence of the fully immunised 
child (FIC) was only 49%, indicating the poor state of vaccination 
coverage in this region and its constituent countries. Although there 
were significant inter-country variations in the prevalence of the 
FIC (ranging from 24% in Nigeria to 81% in Burkina Faso), the 
overall picture highlights the need for increased and consistent 
interventions to improve vaccination coverage in countries of West 
Africa. According to our analyses, some of the worst performing 
countries have made significant progress, but they are still clearly 
far off track towards achieving global vaccination coverage targets.
Although there was no single risk factor/predictor for FIC across all 
the West African countries covered in this study, delivery in a health 
facility and attending a well-baby clinic visit within two months of 
birth were common to over 50% of these countries. The other risk 
factors were less prevalent or relevant to fewer countries. In order to 
identify interventions to increase the proportion of the FIC in these 
countries, multidisciplinary investigations into the social (culture, 
religion, behaviour, etc.), health systems, political and economic 
correlates of childhood vaccination in countries of this region in 
much finer detail is essential.
In particular, this study highlights the enormous gap in the ability 
of healthcare service delivery system to minimize dropouts. The 
proportion of DPT1-to-DPT3 dropouts measure the consistency of 
a vaccination programme in delivering the same antigen(s) multiple 
times over a relatively short period. On the other hand, DPT1-to- 
MCV1 assesses dropouts over an extended period in the life of an 
infant and is considered a better measure of the overall effective-
ness of immunization programs26.
Children in Benin, Cote d’Ivoire, Guinea, Mali, and Nigeria were 
less likely to complete the schedule for repeated vaccines given 
DPT1-to-DPT3 dropout levels were higher than the WHO 10% 
threshold27,28. The reasons for this are not immediately obvious. 
All five countries are ranked quite low on the Human Development 
Index (HDI) with Mali and Guinea among the ten countries with 
the lowest HDI in Africa (http://www.instituto-camoes.pt/images/
cooperacao/relatorio_ocde14b.pdf). However, the conditions of 
Figure 1. Proportion of DPT1-to-MCV1 dropouts among children aged 12–23 months in selected West African countries.
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literacy, life expectancy and income per capital resulting in a low 
HDI rank are only a part of the explanation, since Burkina Faso has 
excellent access and utilization of vaccination services and is also 
among the 10 lowest HDI ranked countries in Africa. Health system 
weaknesses caused by security challenges, civil war, insurgency, 
and political unrest are also very likely contributors. For example, 
Cote d’Ivoire suffered a second civil war in 2011, Guinea and Mali 
experienced health system weaknesses driven by political instabil-
ity and insurgency, which for Guinea in particular, contributed to 
the country being the epicentre of the 2014 Ebola Epidemic. Mali’s 
predominantly rural population, a significant proportion that is 
nomadic scattered across a vast landmass that is the seventh larg-
est in Africa, highlights its challenge with access and utilization of 
immunisation services. That Nigeria is the only country in Africa 
to have never eradicated polio perhaps underscores the challenges 
faced in delivery and access to vaccines, especially in the northern 
part of that country.
Only three countries -Ghana, Gambia and Burkina Faso - had 
acceptable DPT1-to-DPT3 drop-out levels i.e. <10%. The Gambia 
and Burkina Faso have good access to and utilization of immuni-
zation services despite a HDI rank of 175 and 185, respectively, 
suggesting other context specific issues contribute to high child-
hood vaccination coverage. Ghana ranked over 35 places on the 
HDI than Gambia, which is a country where >60% of the popula-
tion live within a convenient distance from a health centre, and 80% 
vaccine coverage was achieved since 199029. Unsurprisingly, the 
same countries with low DPT1-to-DPT3 dropout also had the low-
est DPT1-to-MCV1 dropout, with the surprise inclusion of Benin.
Our findings here are similar to results found in other studies using 
dropout between BCG and MCV130,31. Since all, except the afore-
mentioned countries, had DPT1-to-MCV1 dropout of >10%, there 
is clearly a region-wide problem with retention of infant cohorts 
by immunisation services. With the Ebola-hit countries, Liberia, 
Guinea, and Sierra Leone, which were among those with the high-
est dropout, poor retention confirms that a weak health system is a 
predisposing factor to disease outbreaks and significant mortality 
from VPDs32,33. There are large inter-country differences observed 
in access (DPT1-to-DPT3 drop-out) and utilization (DPT1-to-
MCV1 drop-out) of immunization programmes. In order to identify 
and implement interventions to increase access and utilization, 
affected countries need to conduct in-depth investigations of 
associated risk factors/predictors for poor vaccine coverage and 
healthcare utilization34.
In all countries, except Ghana, having a vaccine card was a sig-
nificant predictor of FIC. Vaccine cards are thought to be essential 
in promoting complete vaccination in children by acting as infor-
mation resources16. Similar to our findings, other studies have also 
shown the importance of vaccine cards in promoting child health 
and immunization13,35.
Delivery in a hospital or a health facility is associated with higher 
vaccine coverage because early contact with the healthcare system 
during and following parturition ensures prompt delivery of birth 
vaccines (BCG, OPV0, and Hepatitis B) and provides an opportu-
nity to reinforce the need for immunization to mothers and other 
caregivers7,21. Similarly, increasing contact time with the healthcare 
system through post-natal appointments has also been associated 
with increased vaccination coverage. As shown in this study, receiv-
ing a check-up within two months of birth was associated with full 
immunisation. These kinds of visits achieve this by affording health 
care workers opportunities to review vaccination histories, and rein-
force (and/or clarify) vaccine-related information. It also results in 
reduced missed opportunities and contributes to higher compliance 
with the childhood immunisation schedule7,36.
It is not surprising that, along with higher maternal age (one coun-
try), maternal education (three countries) was associated with com-
plete vaccination status. Other investigators have reported educated 
mothers tend to have better health care seeking behaviour, due to a 
better understanding of the benefits of medical care, including the 
benefits of spacing their children37.
Our study had some limitations. We used DHS data that is designed 
to be comparative at national and regional levels, so the findings 
here do not have the richness of detail for a finer examination of 
coverage and associated risk factors at the level of districts or set-
tlements. These surveys assess vaccination status by vaccine card 
record and parental recall. Recall of vaccination history introduces 
recall bias. In addition, using vaccine cards as a source document 
from which vaccination histories were obtained alongside recall 
may have introduced some ascertainment bias. It is possible the 
varying effect sizes for vaccine cards observed was driven by card 
retention within countries and the contribution of parental recall to 
the ascertainment of exposure to vaccination, which may overesti-
mate vaccination coverage.
Even with a probability-based sampling design, underserved popu-
lations or those most likely to be unimmunized may be undersam-
pled by vaccination coverage surveys, like DHS. Clusters with a 
larger population are more likely to be selected compared to less 
populated clusters, increasing the risk of oversampling high pop-
ulated areas and making the sample less representative. The net 
effect of this will be exaggerated vaccination coverage. To counter 
this, we applied survey weighting in our analyses.
It would have been useful to examine other sources of survey 
coverage data to validate or triangulate the DHS data used in the 
study. One likely source is from the results of the UNICEF-led 
Multiple Indicator Cluster Surveys (MICS, http://mics.unicef.
org/surveys). However, this was not possible for two key reasons. 
First, the survey years do not overlap, and secondly, there is a slight 
difference in methodology as DHS surveys record all vaccines 
given before the survey, while MICS looks at all vaccines given 
just before the first birthday in the target population. Nonetheless, 
the DHS surveys are rigorously designed and utilize well validated 
methodology.
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